Slotman Gus J, Matthews Martha, Fahey Leilani, Thom Steven, Clark James, Hardy Kevin
Department of Surgery, UMDNJ/Robert Wood Johnson Medical School at Camden, Camden, NJ, USA.
Undersea Hyperb Med. 2011 May-Jun;38(3):159-65.
Complications after radical head and neck cancer surgery in irradiated patients are frequent and life-threatening. Hemorrhage, salivary fistulas, wound infections that expose the carotid sheath, among others, make these patients difficult management challenges in the ICU. We studied the effects of Nd:YAG laser surgery plus hyperbaric oxygen (HBO2) therapy on radical head and neck resections and complex reconstruction as a means of reducing postoperative morbidity and mortality.
43 head and neck cancer patients were reviewed. Eight (STD) had standard surgery; 35 (YAG:HBO2) had Nd:YAG laser and postoperative HBO2.
Age, staging, primary tumor site, sex, reconstruction procedure and transfusion did not differ between STD and YAG/HBO2. All STD and Nd:YAG/HBO2 patients were irradiated, median dosages 5,000 centi-Gray (cGy) and 7,000 cGy, respectively (p = 0.073). Median blood loss was 1,000 ml STD and 700 ml YAG/HBO2 (p = 0.046). There were no postoperative deaths. Major surgical site complications developed in 63% of the STD and 17% of the YAG/HBO2 patients (p = 0.017). All STD and 62% of YAG/HBO2 cancers recurred within 28 months of surgery (p = 0.152). Within the STD and YAG/HBO2 groups, 100% and 77% of deaths, respectively, were due to cancer.
Combined Nd:YAG laser surgery and HBO2 reduces morbidity in radical head and neck cancer surgery. Recurrent disease and poor cancer survival remain common in this high-risk population.
接受过放疗的患者在根治性头颈癌手术后并发症频发且危及生命。出血、唾液瘘、暴露颈动脉鞘的伤口感染等情况,使得这些患者在重症监护病房(ICU)的管理面临巨大挑战。我们研究了钕钇铝石榴石(Nd:YAG)激光手术联合高压氧(HBO₂)治疗对头颈癌根治性切除及复杂重建的影响,以此作为降低术后发病率和死亡率的一种手段。
对43例头颈癌患者进行了回顾性研究。8例(STD组)接受标准手术;35例(YAG:HBO₂组)接受Nd:YAG激光手术及术后HBO₂治疗。
STD组和YAG/HBO₂组在年龄、分期、原发肿瘤部位、性别、重建手术方式及输血情况方面无差异。所有STD组和Nd:YAG/HBO₂组患者均接受过放疗,中位剂量分别为5000厘戈瑞(cGy)和7000 cGy(p = 0.073)。STD组中位失血量为1000毫升,YAG/HBO₂组为700毫升(p = 0.046)。术后无死亡病例。STD组63%的患者和YAG/HBO₂组17%的患者发生了主要手术部位并发症(p = 0.017)。所有STD组患者及YAG/HBO₂组62%的患者在术后28个月内癌症复发(p = 0.152)。在STD组和YAG/HBO₂组中,分别有100%和�%的死亡病例是由癌症导致的。
Nd:YAG激光手术联合HBO₂治疗可降低根治性头颈癌手术的发病率。在这一高危人群中,疾病复发和癌症生存率低的情况仍然很常见。